🔎 Trials Near Me

Akèy › Timò Nèwo-endokrin › Tennessee › Nashville

Etid klinik pou Timò Nèwo-endokrin nan Nashville, TN

6 etid pou Timò Nèwo-endokrin ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • Henry-Joyce Cancer Clinic, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Ap rekriteFaz 1
  • Research Facility, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07165132

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • The Children's Hospital at TriStar Centennial, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Ap rekriteFaz 1/2
  • Vanderbilt-Ingram Cancer Center, Nashville
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Ap rekriteFaz 1/2
  • Sarah Cannon Research Institute, Nashville
Laj 18 a 85 · Tout sèks · Mizajou Jan 29, 2026 · NCT06055439

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Nashville
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Timò Nèwo-endokrin nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.